Human Anti-Epstein Barr virus IgM ELISA Kit (EBV-VCA)
Be the first to review this product! Submit a review
|
(3 Publications)
- Colorimetric readout - 450 nm - Works on any standard plate reader
- Easy results interpretation
- Cut-off, positive and negative controls included
Reactivity data
Product details
Abcam's anti-Epstein Barr virus (EBV-VCA) IgM Human in vitro ELISA (Enzyme-Linked Immunosorbent Assay) kit is designed for the accurate qualitative measurement of IgM class antibodies against Epstein Barr virus in Human serum and plasma.
A 96-well plate has been precoated with Epstein Barr virus antigens to bind cognate antibodies. Controls or test samples are added to the wells and incubated. Following washing, a horseradish peroxidase (HRP) labelled anti-Human IgM conjugate is added to the wells, which binds to the immobilized Epstein Barr virus-specific antibodies. TMB is then catalyzed by the HRP to produce a blue color product that changes to yellow after adding an acidic stop solution. The density of yellow coloration is directly proportional to the amount of Epstein Barr virus IgM sample captured in plate.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Precision
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EBV VCA IgM is integral to the body's initial immune response against the Epstein-Barr Virus. It is not part of a larger protein complex but operates independently as an antibody that detects viral antigens. It binds to the Epstein-Barr early antigens facilitating neutralization and clearance of the virus. Its presence indicates a recent EBV infection and is important for diagnosing infectious mononucleosis commonly called mono.
Pathways
EBV VCA IgM is involved in the immune response pathways particularly humoral immune processes. This antibody participates in the activation of the complement cascade enhancing opsonization and phagocytosis of the virus by immune cells. It closely relates to another antibody EBV IgG which appears later in the infection cycle indicating past exposure and ongoing immune response maintenance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Open forum infectious diseases 11:ofae693 PubMed39703789
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation (London, England) 21:30 PubMed39135051
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunology research 2022:4363927 PubMed36405008
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com